Avantor, Inc. Common Stock (AVTR)

Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the man...

Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad t...

Avantor (NYSE:AVTR) reported a return to organic revenue growth in the third quarter of 2026, led by accelerating performance in its VWR Distribution & Services segment and a return to growth in its Bioscience & Medtech Products business. Revenue totaled $1.698 billion, up 5.2% organically

Ligner discusses return to organic growth and Revival program progress.

Life sciences company Avantor (NYSE:AVTR) beat Wall Street’s revenue expectations in Q3 2026, with revenue up 4.6% year on year to $1.70 billion. Its non-GAA...

Life sciences company Avantor (NYSE:AVTR) will be reporting results this Wednesday before market open. Here’s what investors should know. Avantor beat analys...

What a time it’s been for Avantor. In the past six months alone, the company’s stock price has increased by a massive 89.4%, reaching $15.49 per share. This ...

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at ...

Running at a loss can be a red flag. Many of these businesses face mounting challenges as competition increases and funding becomes harder to secure. A lack ...

Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges. However...

When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fea...

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a...

Management raised full-year guidance after returning to organic growth in distribution.

Avantor’s second quarter was marked by a positive market response, as results surpassed Wall Street expectations for both revenue and non-GAAP earnings. Mana...

Life sciences company Avantor (NYSE:AVTR) beat Wall Street’s revenue expectations in Q2 CY2026, but sales were flat year on year at $1.69 billion. Its non-GA...

Avantor (NYSE:AVTR) reported second-quarter 2026 results that exceeded its expectations on several measures, supported by a return to organic growth in its VWR Distribution & Services segment, strong free cash flow and progress under its Revival operational improvement program. Revenue totaled

Life sciences company Avantor (NYSE:AVTR) beat Wall Street’s revenue expectations in Q2 CY2026, but sales were flat year on year at $1.69 billion. Its non-GA...

Life sciences company Avantor (NYSE:AVTR) will be reporting results this Wednesday before market hours. Here’s what investors should know. Avantor beat analy...

Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges. However...

Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad t...

Value investing has produced some of the world’s most famous investing billionaires, including Warren Buffett, David Einhorn, and Seth Klarman, who built the...

Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in th...

What Happened? Shares of life sciences company Avantor (NYSE:AVTR) jumped 3.2% in the morning session after an analyst at Barclays boosted their price target...